{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:22:34Z","timestamp":1794295354635,"version":"4.9.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","award":["R01MH09S776A1"],"award-info":[{"award-number":["R01MH09S776A1"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001455","name":"American Foundation for Suicide Prevention","doi-asserted-by":"publisher","award":["66324S-13"],"award-info":[{"award-number":["66324S-13"]}],"id":[{"id":"10.13039\/100001455","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lumosity Corporation","award":["8S0073-9"],"award-info":[{"award-number":["8S0073-9"]}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000971","name":"ALS Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008035","name":"Harvard Stem Cell Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008035","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Neurologic Clinical Research Institute","award":["701419-18"],"award-info":[{"award-number":["701419-18"]}]},{"name":"MECTA Corporation","award":["72200S-2"],"award-info":[{"award-number":["72200S-2"]}]},{"name":"ABR Corporation"},{"name":"Veterans Administration"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.psc.2018.04.002","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T19:05:24Z","timestamp":1529089524000},"page":"355-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["When All Else Fails"],"prefix":"10.1016","volume":"41","author":[{"given":"Peter B.","family":"Rosenquist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagy A.","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandarsh","family":"Surya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William V.","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.psc.2018.04.002_bib1","first-page":"75","article-title":"The FDA and ECT","volume":"32","author":"McDonald","year":"2016","journal-title":"J\u00a0ECT"},{"key":"10.1016\/j.psc.2018.04.002_bib2","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration. Electroconvulsive therapy (ECT) devices for class II intended uses. Rockville (MD): 2015. Available at: https:\/\/www.gpo.gov\/fdsys\/pkg\/FR-2015-32592.pdf. Accessed May 1, 2018."},{"issue":"9","key":"10.1016\/j.psc.2018.04.002_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archinte.166.9.1021","article-title":"Off-label prescribing among office-based physicians","volume":"166","author":"Radley","year":"2006","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.psc.2018.04.002_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/schbul\/sbp130","article-title":"The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009","volume":"36","author":"Kreyenbuhl","year":"2010","journal-title":"Schizophr Bull"},{"issue":"5","key":"10.1016\/j.psc.2018.04.002_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/15622975.2012.696143","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance","volume":"13","author":"Hasan","year":"2012","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.psc.2018.04.002_bib6","unstructured":"National Institute for Health and Clinical Excellence. NICE technology appraisal guidance No.59: The clinical effectiveness and cost effectiveness of electroconvulsive therapy (ECT) for depressive illness, schizophrenia, catatonia and mania. 2003. Available at: https:\/\/www.nice.org.uk\/guidance\/ta59. Accessed May 1, 2018."},{"issue":"2","key":"10.1016\/j.psc.2018.04.002_bib7","article-title":"Electroconvulsive therapy for schizophrenia","author":"Tharyan","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.psc.2018.04.002_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1192\/bjp.146.2.177","article-title":"Leicester ECT trial: results in schizophrenia","volume":"146","author":"Brandon","year":"1985","journal-title":"Br J Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2018.04.002_bib9","first-page":"271","article-title":"An exploratory evaluation of ECT in haloperidol-treated DSM-IIIR schizophreniform disorder","volume":"10","author":"Sarkar","year":"1994","journal-title":"Convuls Ther"},{"issue":"3","key":"10.1016\/j.psc.2018.04.002_bib10","first-page":"237","article-title":"A\u00a0controlled trial of modified electroconvulsive therapy in schizophrenia in a Nigerian teaching hospital","volume":"21","author":"Ukpong","year":"2002","journal-title":"West Afr J Med"},{"issue":"23","key":"10.1016\/j.psc.2018.04.002_bib11","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.3923\/pjbs.2007.4287.4290","article-title":"Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients","volume":"10","author":"Masoudzadeh","year":"2007","journal-title":"Pak J Biol Sci"},{"key":"10.1016\/j.psc.2018.04.002_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1192\/bjp.151.2.152","article-title":"The efficacy of electroconvulsive therapy in the treatment of schizophrenia. A comparative study","volume":"151","author":"Abraham","year":"1987","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2018.04.002_bib13","first-page":"26","article-title":"Efficacy of electroconvulsive therapy in treatment resistant schizophrenia: a double-blind study","volume":"45","author":"Goswami","year":"2003","journal-title":"Indian J Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2018.04.002_bib14","first-page":"178","article-title":"Continuation ECT in treatment-resistant schizophrenia: a controlled study","volume":"15","author":"Chanpattana","year":"1999","journal-title":"J\u00a0ECT"},{"issue":"1\u20132","key":"10.1016\/j.psc.2018.04.002_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-1781(01)00321-3","article-title":"Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia: prediction of outcome","volume":"105","author":"Chanpattana","year":"2001","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.psc.2018.04.002_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1176\/appi.ajp.2014.13060787","article-title":"Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study","volume":"172","author":"Petrides","year":"2015","journal-title":"Am J Psychiatry"},{"issue":"572","key":"10.1016\/j.psc.2018.04.002_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1192\/bjp.123.1.73","article-title":"Unilateral versus bilateral ECT in schizophrenia","volume":"123","author":"Doongaji","year":"1973","journal-title":"Br J Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2018.04.002_bib18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.brs.2012.04.002","article-title":"Double-blind randomized controlled study showing symptomatic and cognitive superiority of bifrontal over bitemporal electrode placement during electroconvulsive therapy for schizophrenia","volume":"6","author":"Phutane","year":"2013","journal-title":"Brain Stimul"},{"issue":"10","key":"10.1016\/j.psc.2018.04.002_bib19","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1590\/0004-282X20160130","article-title":"The maintenance of modified electroconvulsive therapy combined with risperidone is better than risperidone alone in preventing relapse of schizophrenia and improving cognitive function","volume":"74","author":"Yang","year":"2016","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.psc.2018.04.002_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/acps.12717","article-title":"Is there consensus across international evidence-based guidelines for the management of bipolar disorder?","volume":"135","author":"Parker","year":"2017","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"10.1016\/j.psc.2018.04.002_bib21","first-page":"153","article-title":"Efficacy and safety of electroconvulsive therapy in the treatment of bipolar disorder","volume":"27","author":"Versiani","year":"2011","journal-title":"J\u00a0ECT"},{"key":"10.1016\/j.psc.2018.04.002_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/1570159X14666161017233642","article-title":"The role of electroconvulsive therapy (ECT) in bipolar disorder: effectiveness in 522 patients with bipolar depression, mixed-state, mania and catatonic features","volume":"15","author":"Perugi","year":"2017","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"10.1016\/j.psc.2018.04.002_bib23","first-page":"1","article-title":"Uni- versus bilateral ECT in the treatment of mania","volume":"3","author":"Milstein","year":"1987","journal-title":"Convulsive Ther"},{"key":"10.1016\/j.psc.2018.04.002_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archpsyc.1988.01800320037004","article-title":"Electroconvulsive treatment compared with lithium in the management of manic states","volume":"45","author":"Small","year":"1988","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2018.04.002_bib25","first-page":"74","article-title":"Unilateral ECT in the treatment of manic episodes","volume":"4","author":"Mukherjee","year":"1988","journal-title":"Convulsive Ther"},{"key":"10.1016\/j.psc.2018.04.002_bib26","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1192\/bjp.164.6.806","article-title":"Combined chlorpromazine and electroconvulsive therapy in mania","volume":"164","author":"Sikdar","year":"1994","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.psc.2018.04.002_bib27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1399-5618.2008.00608.x","article-title":"Double-blind randomized controlled study comparing short-term efficacy of bifrontal and bitemporal electroconvulsive therapy in acute mania","volume":"10","author":"Hiremani","year":"2008","journal-title":"Bipolar Disord"},{"issue":"3","key":"10.1016\/j.psc.2018.04.002_bib28","first-page":"199","article-title":"Bifrontal versus bitemporal electroconvulsive therapy in severe manic patients","volume":"24","author":"Barekatain","year":"2008","journal-title":"J\u00a0ECT"},{"key":"10.1016\/j.psc.2018.04.002_bib29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1399-5618.2009.00668.x","article-title":"Effects of stimulus intensity on the efficacy and safety of twice-weekly, unilateral electroconvulsive therapy (ECT) combined with antipsychotics in acute mania: a randomised clinical trial","volume":"11","author":"Mohan","year":"2009","journal-title":"Bipolar Disord"},{"issue":"2","key":"10.1016\/j.psc.2018.04.002_bib30","first-page":"63","article-title":"Symptomatic predictors of ECT response in medication-nonresponsive manic patients","volume":"53","author":"Schnur","year":"1992","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2018.04.002_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/ajp.151.2.169","article-title":"Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience","volume":"151","author":"Mukherjee","year":"1994","journal-title":"Am J Psychiatry"},{"issue":"11\u201312","key":"10.1016\/j.psc.2018.04.002_bib32","first-page":"27","article-title":"ECT-induced mania","volume":"11","author":"Lee","year":"2014","journal-title":"Innov Clin Neurosci"},{"key":"10.1016\/j.psc.2018.04.002_bib33","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1080\/15622970902838242","article-title":"Frequency of and rationale for the combined use of electroconvulsive therapy and antiepileptic drugs in Austria and the literature","volume":"10","author":"Rubner","year":"2009","journal-title":"World J Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.psc.2018.04.002_bib34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0006-3223(88)90006-6","article-title":"Complications of concurrent lithium and electroconvulsive therapy: a review of clinical material and theoretical considerations","volume":"23","author":"el-Mallakh","year":"1988","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2018.04.002_bib35","doi-asserted-by":"crossref","first-page":"E33","DOI":"10.1176\/appi.neuropsych.11110321","article-title":"Lithium plus ECT in mania in 90 cases: safety issues","volume":"24","author":"Volpe","year":"2012","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.psc.2018.04.002_bib36","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4088\/JCP.v62n07a09","article-title":"Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression","volume":"62","author":"Ciapparelli","year":"2001","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"Suppl 2","key":"10.1016\/j.psc.2018.04.002_bib37","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1590\/S1516-44462007000600005","article-title":"Antipsychotics, anticonvulsants, antiadrenergics and other drugs: what to do when posttraumatic stress disorder does not respond to selective serotonin reuptake inhibitors?","volume":"29","author":"Berger","year":"2007","journal-title":"Rev Bras Psiquiatr"},{"issue":"1","key":"10.1016\/j.psc.2018.04.002_bib38","first-page":"62","article-title":"The role of ECT in posttraumatic stress disorder: a systematic review","volume":"29","author":"Youssef","year":"2017","journal-title":"Ann Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2018.04.002_bib39","first-page":"93","article-title":"Electroconvulsive therapy for comorbid major depressive disorder and posttraumatic stress disorder","volume":"23","author":"Watts","year":"2007","journal-title":"J\u00a0ECT"},{"issue":"7","key":"10.1016\/j.psc.2018.04.002_bib40","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/da.22451","article-title":"Efficacy and long-term clinical outcome of comorbid posttraumatic stress disorder and major depressive disorder after electroconvulsive therapy","volume":"33","author":"Ahmadi","year":"2016","journal-title":"Depress Anxiety"},{"issue":"1","key":"10.1016\/j.psc.2018.04.002_bib41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brs.2009.04.005","article-title":"Efficacy of ECT in chronic, severe, antidepressant- and CBT-refractory PTSD: an open, prospective study","volume":"3","author":"Margoob","year":"2010","journal-title":"Brain Stimul"},{"issue":"1","key":"10.1016\/j.psc.2018.04.002_bib42","first-page":"21","article-title":"Fatal pulmonary embolism in the catatonic syndrome: two case reports and a literature review","volume":"56","author":"McCall","year":"1995","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"8","key":"10.1016\/j.psc.2018.04.002_bib43","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/jnnp-2014-309098","article-title":"Movement disorders in catatonia","volume":"86","author":"Wijemanne","year":"2015","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.psc.2018.04.002_bib44","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/archgenpsychiatry.2009.141","article-title":"The catatonia syndrome: forgotten but not gone","volume":"66","author":"Fink","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2018.04.002_bib45","first-page":"174","article-title":"The response to an amobarbital interview as a predictor of therapeutic outcome in patients with catatonic mutism","volume":"8","author":"McCall","year":"1992","journal-title":"Convuls Ther"},{"issue":"4","key":"10.1016\/j.psc.2018.04.002_bib46","first-page":"233","article-title":"Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms","volume":"23","author":"Hatta","year":"2007","journal-title":"J\u00a0ECT"},{"issue":"8","key":"10.1016\/j.psc.2018.04.002_bib47","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/bdi.12348","article-title":"Catatonia in 26 patients with bipolar disorder: clinical features and response to electroconvulsive therapy","volume":"17","author":"Medda","year":"2015","journal-title":"Bipolar Disord"},{"issue":"2","key":"10.1016\/j.psc.2018.04.002_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0447.1996.tb09814.x","article-title":"Catatonia. I. Rating scale and standardized examination","volume":"93","author":"Bush","year":"1996","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"10.1016\/j.psc.2018.04.002_bib49","first-page":"3","article-title":"Determinants of seizure threshold in ECT: benzodiazepine use, anesthetic dosage, and other factors","volume":"16","author":"Boylan","year":"2000","journal-title":"J\u00a0ECT"},{"issue":"5","key":"10.1016\/j.psc.2018.04.002_bib50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0006-3223(96)00378-2","article-title":"Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia","volume":"42","author":"Petrides","year":"1997","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2018.04.002_bib51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5498\/wjp.v6.i4.391","article-title":"Catatonia: our current understanding of its diagnosis, treatment and pathophysiology","volume":"6","author":"Rasmussen","year":"2016","journal-title":"World J Psychiatry"},{"issue":"6","key":"10.1016\/j.psc.2018.04.002_bib52","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-3999(00)00190-2","article-title":"Clinical and cerebral blood flow changes in catatonic patients treated with ECT","volume":"49","author":"Escobar","year":"2000","journal-title":"J\u00a0Psychosom Res"},{"issue":"2","key":"10.1016\/j.psc.2018.04.002_bib53","first-page":"73","article-title":"Short-term effect of ECT in middle-aged and elderly patients with intractable catatonic schizophrenia","volume":"19","author":"Suzuki","year":"2003","journal-title":"J\u00a0ECT"},{"issue":"2","key":"10.1016\/j.psc.2018.04.002_bib54","first-page":"99","article-title":"One-year outcome after response to ECT in middle-aged and elderly patients with intractable catatonic schizophrenia","volume":"20","author":"Suzuki","year":"2004","journal-title":"J\u00a0ECT"},{"issue":"4","key":"10.1016\/j.psc.2018.04.002_bib55","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1440-1819.2005.01402.x","article-title":"Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia","volume":"59","author":"Suzuki","year":"2005","journal-title":"Psychiatry Clin Neurosci"},{"issue":"6","key":"10.1016\/j.psc.2018.04.002_bib56","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.genhosppsych.2010.08.007","article-title":"A\u00a0retrospective study of 34 catatonic patients: analysis of clinical care and treatment","volume":"32","author":"Tuerlings","year":"2010","journal-title":"Gen Hosp Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2018.04.002_bib57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archneur.1996.00550020087019","article-title":"The occurrence of depression in Parkinson's disease. A community-based study","volume":"53","author":"Tandberg","year":"1996","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.psc.2018.04.002_bib58","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/npp.2010.182","article-title":"Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates","volume":"36","author":"Landau","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.psc.2018.04.002_bib59","first-page":"116","article-title":"Neurotransmitters and electroconvulsive therapy","volume":"30","author":"Baldinger","year":"2014","journal-title":"J\u00a0ECT"},{"issue":"3","key":"10.1016\/j.psc.2018.04.002_bib60","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1176\/ajp.132.3.283","article-title":"Improvement of Parkinsonism in depressed patients treated with ECT","volume":"132","author":"Lebensohn","year":"1975","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2018.04.002_bib61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2217\/nmt-2016-0002","article-title":"Electroconvulsive therapy for depression in Parkinson's disease: systematic review of evidence and recommendations","volume":"6","author":"Borisovskaya","year":"2016","journal-title":"Neurodegener Dis Manag"},{"issue":"3","key":"10.1016\/j.psc.2018.04.002_bib62","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1600-0404.1987.tb03566.x","article-title":"A\u00a0double-blind evaluation of electroconvulsive therapy in Parkinson's disease with \"on-off\" phenomena","volume":"76","author":"Andersen","year":"1987","journal-title":"Acta Neurol Scand"},{"issue":"11","key":"10.1016\/j.psc.2018.04.002_bib63","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1176\/ajp.146.11.1451","article-title":"ECT and Parkinson's disease revisited: a \"naturalistic\" study","volume":"146","author":"Douyon","year":"1989","journal-title":"Am J Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.psc.2018.04.002_bib64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF02251228","article-title":"ECT in Parkinson's disease. Changes in motor symptoms, monoamine metabolites and neuropeptides","volume":"10","author":"Fall","year":"1995","journal-title":"J\u00a0Neural Transm Park Dis Dement Sect"}],"container-title":["Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X18310980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X18310980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T19:02:49Z","timestamp":1539111769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0193953X18310980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0193953X18310980"],"URL":"https:\/\/doi.org\/10.1016\/j.psc.2018.04.002","relation":{},"ISSN":["0193-953X"],"issn-type":[{"value":"0193-953X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When All Else Fails","name":"articletitle","label":"Article Title"},{"value":"Psychiatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psc.2018.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}